GGrantIndex
← Search

PREVENTION OF SERIOUS BACTERIAL IN HIV CHILDREN

$0M01FY2000RRNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Abstract

In this Phase II/III study, the regimen of azithromycin plus atovaquone is being compared to trimethoprim-sulfamethoxazole in the prevention of serious bacterial infections among 2-18 year old HIV-infected children. Pneumocystis carinii breakthrough rates and the occurrence of other opportunistic infections is also being monitored. Two children have been enrolled in this study at JHU.

View original record on NIH RePORTER →